MoneyWorks4Me

Kopran - Quaterly Results

07 Feb 2024 Evaluate
A fair growth of 21.14% in the revenue at Rs. 823.34 millions was reported in the December 2023 quarter as compared to Rs. 679.64 millions during year-ago period.Net Profit witnessed a 110.44% growth almost the double from Rs. 40.44 millions to Rs. 85.10  millions  of same quarter last year.Operating profit surged to 133.54 millions from the corresponding previous quarter of 72.63 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202312 202212 % Var 202312 202212 % Var 202303 202203 % Var
Sales 823.34 679.64 21.14 2468.33 1927.67 28.05 2730.95 2045.20 33.53
Other Income 12.91 11.61 11.20 85.62 160.72 -46.73 160.86 80.27 100.40
PBIDT 133.54 72.63 83.86 301.47 345.62 -12.77 439.99 234.40 87.71
Interest 10.25 7.22 41.97 27.22 18.30 48.74 26.72 29.53 -9.52
PBDT 123.29 65.41 88.49 274.25 327.32 -16.21 413.27 204.87 101.72
Depreciation 11.72 11.19 4.74 34.59 33.23 4.09 44.12 43.23 2.06
PBT 111.57 54.22 105.77 239.66 294.09 -18.51 369.15 161.64 128.38
TAX 26.47 13.78 92.09 46.39 36.74 26.27 56.63 44.20 28.12
Deferred Tax -1.50 0.45 -433.33 -2.13 -2.31 -7.79 -2.09 6.73 -131.05
PAT 85.10 40.44 110.44 193.27 257.35 -24.90 312.52 117.44 166.11
Equity 482.11 482.11 0.00 482.11 482.11 0.00 482.12 482.12 0.00
PBIDTM(%) 16.22 10.69 51.77 12.21 17.93 -31.88 16.11 11.46 40.57
Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..